Progetto Odin

Corso FAD ECM Proteggere dall’influenza con la vaccinazione Corso FAD da 45 crediti ECM online fino al 31 dicembre 2018

Starting Dose of Sorafenib for the Treatment of Hepatocellular Carcinoma: A Retrospective, Multi-Institutional Study

Starting Dose of Sorafenib for the Treatment of Hepatocellular Carcinoma: A Retrospective, Multi-Institutional Study – Progetto di formazione e aggiornamento in oncologia Sorafenib is currently the only Food and Drug Administration–approved first-line therapy for patients with advanced hepatocellular carcinoma. There are few data examining how sorafenib starting dose...

The Lipid Kinase PIKfyve Coordinates the Neutrophil Immune Response through the Activation of the Rac GTPase [INNATE IMMUNITY AND INFLAMMATION]

The Lipid Kinase PIKfyve Coordinates the Neutrophil Immune Response through the Activation of the Rac GTPase [INNATE IMMUNITY AND INFLAMMATION] – Progetto di formazione e aggiornamento in oncologia Abstract

Dynamic Molecular Analysis and Clinical Correlates of Tumor Evolution Within a Phase 2 Trial of Panitumumab-Based Therapy in Metastatic Colorectal Cancer

Dynamic Molecular Analysis and Clinical Correlates of Tumor Evolution Within a Phase 2 Trial of Panitumumab-Based Therapy in Metastatic Colorectal Cancer – Progetto di formazione e aggiornamento in oncologia Background: Mutations in rat sarcoma (RAS) genes may be a mechanism of secondary resistance in EGFR inhibitor−treated patients. Tumor-tissue biopsy testing has been the standard for evaluating mutational...

Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy

Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy – Progetto di formazione e aggiornamento in oncologia Supported by Cancer Research U.K. (CRUK_A12459), Medical Research Council (MRC_MC_UU_12023/25), Astellas Pharma, Clovis Oncology, Janssen, Novartis, Pfizer, and Sanofi-Aventis.

Randomized Phase II Study of R-CHOP With or Without Bortezomib in Previously Untreated Patients With Non–Germinal Center B-Cell–Like Diffuse Large B-Cell Lymphoma

Randomized Phase II Study of R-CHOP With or Without Bortezomib in Previously Untreated Patients With Non–Germinal Center B-Cell–Like Diffuse Large B-Cell Lymphoma – Progetto di formazione e aggiornamento in oncologia To evaluate the impact of the addition of bortezomib to rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) on outcomes in previously untreated patients with non–germinal...

Breast Mass Discovered in 49-Year-Old Patient https://buff.ly/2eMtOhT

EHR Vendors Seek Clarity from CMS

EHR Vendors Seek Clarity from CMS – Progetto di formazione e aggiornamento in oncologia Welcome to Practice Rounds, our weekly column exploring what’s being covered in the larger world of healthcare.